Rachel K. King
2014
In 2014, Rachel K. King earned a total compensation of $2.9M as President and Chief Executive Officer at GlycoMimetics, a 532% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $156,713 |
|---|---|
| Option Awards | $2,302,667 |
| Salary | $417,005 |
| Total | $2,876,385 |
King received $2.3M in option awards, accounting for 80% of the total pay in 2014.
King also received $156.7K in non-equity incentive plan and $417K in salary.
Rankings
In 2014, Rachel K. King's compensation ranked 3,166th out of 13,032 executives tracked by ExecPay. In other words, King earned more than 75.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,166 out of 13,032 | 76th |
Division Manufacturing | 1,120 out of 4,966 | 77th |
Major group Chemicals And Allied Products | 361 out of 1,686 | 79th |
Industry group Drugs | 284 out of 1,365 | 79th |
Industry Pharmaceutical Preparations | 232 out of 1,043 | 78th |
Source: SEC filing on April 11, 2016.
King's colleagues
We found three more compensation records of executives who worked with Rachel K. King at GlycoMimetics in 2014.